Last reviewed · How we verify

NCT07212504: NACC-EC

Effect of Accelerated Neuromodulation of Anterior Cingulate Cortex to Enhance Cognition in Older Adults With Mild Memory Problems

Recruiting now NA Last updated 28 October 2025
What this trial tests

NA trial testing Active Brainsway H7-Coil Deep TMS System in Mild Cognitive Impairment (MCI) in 30 participants. Currently enrolling.

Timeline
15 November 2025
Primary endpoint
15 March 2027
15 March 2027

Quick facts

Lead sponsorRotman Research Institute at Baycrest
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment30
Start date15 November 2025
Primary completion15 March 2027
Estimated completion15 March 2027
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Rotman Research Institute at Baycrest

Who can join

Adults 55 to 85, any sex, with Mild Cognitive Impairment (MCI) or Subjective Cognitive Decline (SCD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to test whether an accelerated deep Transcranial Magnetic Stimulation (dTMS) protocol in combination with cognitive training can improve cognitive abilities in older adults with Subjective Cognitive Decline (SCD) or Mild Cognitive Impairment (MCI). The study will look at whether it is safe and tolerable to use accelerated dTMS to enhance the benefits of cognitive training in older adults, and will also gather early information on the effects of accelerated dTMS on memory and other cognitive abilities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Active Brainsway H7-Coil Deep TMS System

Trials testing the same drug.

Other recruiting trials for Mild Cognitive Impairment (MCI)

Currently open trials in the same condition.

Other Rotman Research Institute at Baycrest trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07212504.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing